Respiratory and Pulmonary System Cystic Fibrosis

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Cystic Fibrosis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Cystic Fibrosis Projects
--ALIGN Pharmaceuticals
--Aerovance, Inc.
--Apotex Inc.
--AOP Orphan Pharmaceuticals AG
--Biovitrum AB
--Aradigm Corp
--Forest Laboratories Inc
--Debiopharm Group
--Kamada Ltd.
--Gilead Sciences Inc
--Meristem Therapeutics
--Lantibio, Inc.
--Nektar Therapeutics
--Milkhaus Laboratory, Inc.
--Parion Sciences, Inc.
--PARI Pharma
--erly PARI Aerosol Research Institute)
--PTC Therapeutics Inc.
--Polydex Pharmaceuticals Ltd
--Vertex Pharmaceuticals Inc
--Talecris Biotherapeutics

--Top Companies in early stage Cystic Fibrosis Projects
--AstraZeneca Plc
--Arriva Pharmaceuticals, Inc
--Helix BioMedix Inc
--GlaxoSmithKline plc
--ISM Therapeutics
--erly Inologic)
--Hollis-Eden Pharmaceuticals Inc
--ParinGenix Inc.
--Mpex Pharmaceuticals
--Theratechnologies, Inc.
--Sucampo Pharmaceuticals, Inc.
--Vertex Pharmaceuticals Inc
--Vectura Group plc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View